logo

For the Inventor, By the Inventor

New City, NY, United States of America

Wojciech J Ardelt

This inventor holds 12 USPTO granted patents and 1 published patent application. Top assignees: Alfacell Corporation, Tamir Biotechnology, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1989-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wojciech J Ardelt. Retrieved from https://idiyas.com/inventor/wojciech-j-ardelt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 91.7

Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 104(Granted Patents)


Location History:

  • Passaic, NJ (US) (1989 - 1996)
  • New City, NY (US) (1996 - 2014)

Company Filing History:

goldMedal7 out of 20 
 
Alfacell Corporation
 patents
silverMedal3 out of 6 
 
Tamir Biotechnology, Inc.
 patents
bronzeMedal2 out of 3,697 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents

Years Active: 1989-2014

Loading Chart...
12 patents (USPTO):Explore Patents
1. 8808690 - Methods of treating infections originating from viruses in the herpesviridae family (2014-08-19),
2. 8663964 - Methods of treating human papillomavirus (2014-03-04),
3. 8518399 - Methods of treating infections originating from viruses in the herpesviridae family (2013-08-27),
4. 6649393 - Mutant form of cytotoxic ribonucleolytic protein which allows production by recombinant methods (2003-11-18),
5. 6649392 - Mutant form of a cytotoxic ribonucleolytic protein which allows production by recombinant methods (2003-11-18),
6. 6239257 - Family of proteins belonging to the pancreatic ribonuclease a superfamily (2001-05-29),
7. 5728805 - Pharmaceuticals and method for making them (1998-03-17),
8. 5595734 - Compositions comprising ONCONASE (tm) and lovastatin (1997-01-21),
9. 5559212 - Frog embryo and egg-derived tumor cell anti-proliferation protein (1996-09-24),
10. 5540925 - Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMOXIFEN (1996-07-30),
11. 5529775 - Compositions comprising ONCONASE(.TM.) and cisplatin, melphalan, or (1996-06-25),
12. 4882421 - Pharmaceutical for treating tumors and method for making it (1989-11-21),

Title: Wojciech J Ardelt: Innovator in Antiviral Research

Introduction

Wojciech J Ardelt is a notable inventor based in New City, NY, who has made significant contributions to the field of antiviral treatments. With a total of 12 patents to his name, his work focuses primarily on methods to combat infections caused by viruses in the herpesviridae family and human papillomavirus (HPV).

Latest Patents

Among his latest patents, Ardelt has developed innovative methods for treating infections originating from the herpesviridae family. His work includes three RNases, specifically ranpirnase, the second embodiment disclosed in U.S. Pat. No. 5,728,805, and recombinant Amphinase-2, which have been tested for their anti-viral activity against various herpesviridae infections. Furthermore, he has explored methods of treating human papillomavirus, where ranpirnase and the second embodiment disclosed in U.S. Pat. No. 5,728,805 have shown promising anti-viral activity against type 11 HPV through quantitative RT-PCR assays.

Career Highlights

Ardelt's career has been marked by his affiliation with prominent organizations in the biotechnology field, including Alfacell Corporation and Tamir Biotechnology, Inc. His innovative research and development efforts have positioned him as a key figure in antiviral therapies, significantly impacting medical science.

Collaborations

Throughout his career, Wojciech J Ardelt has collaborated with notable peers, including Stanislaw M Mikulski and Shailendra K Saxena. These collaborations have enriched his research and led to advancements in the treatment of viral infections.

Conclusion

Wojciech J Ardelt continues to contribute to the scientific community through his inventive approaches to combating viral infections. His patents represent a commitment to advancing medical treatments, showcasing the importance of innovation in the ongoing battle against viruses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…